Oramorph (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Oramorph, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oramorph is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides effective relief after surgical procedures. - Cancer‑related pain: helps manage persistent pain associated with malignant disease. - Severe chronic pain: reduces pain intensity in conditions such as advanced osteoarthritis when other treatments fail.

Morphine sulfate may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Dry mouth - Sweating - Itching (pruritus)

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Bradycardia - Hallucinations or delirium - Severe allergic reactions (anaphylaxis) - Dependence, tolerance and withdrawal symptoms

When using Oramorph, careful monitoring and adherence to safety guidelines are essential.

- Assess patient’s history of substance use: review risk of abuse and dependence. - Adjust dose for renal or hepatic impairment: use lower initial doses and titrate cautiously. - Avoid concomitant central nervous system depressants: monitor for enhanced sedation. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose changes. - Educate patients on proper use and storage: emphasize that the medication is for oral use only and should not be shared. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Morphine sulfate can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - C‑ ​       ​  ​  ​   ​  ​  ​   ​  ​   ​  ​  ​  ​   ​  C  ​  ​  ​  ​

Moderate Interactions (Monitor Closely): - C   - C  - C  - C  - C